Literature DB >> 8855258

Human blood-mobilized hematopoietic precursors differentiate into osteoclasts in the absence of stromal cells.

A Matayoshi1, C Brown, J F DiPersio, J Haug, Y Abu-Amer, H Liapis, R Kuestner, R Pacifici.   

Abstract

Osteoclastogenesis is a complex process that is facilitated by bone marrow stromal cells (SCs). To determine if SCs are an absolute requirement for the differentiation of human hematopoietic precursors into fully mature, osteoclasts (OCs), CD34+ cells were mobilized into the peripheral circulation with granulocyte colony-stimulating factor, harvested by leukapheresis, and purified by magnetic-activated cell sorting. This procedure yields a population of CD34+ cells that does not contain SC precursors, as assessed by the lack of expression of the SC antigen Stro-1, and that differentiates only into hematopoietic cells. We found that CD34+, Stro-1- cells cultured with a combination of granulocyte/macrophage colony-stimulating factor, interleukin 1, and interleukin 3 generated cells that fulfill current criteria for the characterization of OCs, including multinucleation, presence of tartrate-resistant acid phosphatase, and expression of the calcitonin and vitronectin receptors and of pp60c-src tyrosine kinase. These OCs also expressed mRNA for the noninserted isoform of the calcitonin receptor and excavated characteristic resorption pits in devitalized bone slices. These data demonstrate that accessory SCs are not essential for human osteoclastogenesis and that granulocyte colony-stimulating factor treatment mobilizes OC precursors into the peripheral circulation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8855258      PMCID: PMC38233          DOI: 10.1073/pnas.93.20.10785

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Localisation of pp60c-src to the surface membrane of human platelets.

Authors:  R Anand; J M Wilkinson; S Kellie
Journal:  Oncogene       Date:  1993-11       Impact factor: 9.867

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 3.  Cytokines and estrogen in bone: anti-osteoporotic effects.

Authors:  M C Horowitz
Journal:  Science       Date:  1993-04-30       Impact factor: 47.728

4.  Isolation and characterization of CD34+ hematopoietic stem cells from human peripheral blood by high-gradient magnetic cell sorting.

Authors:  K Kato; A Radbruch
Journal:  Cytometry       Date:  1993

5.  Cellular and hormonal factors influencing monocyte differentiation to osteoclastic bone-resorbing cells.

Authors:  J M Quinn; J O McGee; N A Athanasou
Journal:  Endocrinology       Date:  1994-06       Impact factor: 4.736

6.  The biological roles of the third component of complement in osteoclast formation.

Authors:  T Sato; E Abe; C H Jin; M H Hong; T Katagiri; T Kinoshita; N Amizuka; H Ozawa; T Suda
Journal:  Endocrinology       Date:  1993-07       Impact factor: 4.736

7.  Identification and characterization of osteoclast progenitors by clonal analysis of hematopoietic cells.

Authors:  M Y Lee; J L Lottsfeldt; K L Fevold
Journal:  Blood       Date:  1992-10-01       Impact factor: 22.113

8.  Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors.

Authors:  S Tanaka; N Takahashi; N Udagawa; T Tamura; T Akatsu; E R Stanley; T Kurokawa; T Suda
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

9.  Cloning and characterization of an abundant subtype of the human calcitonin receptor.

Authors:  R E Kuestner; R D Elrod; F J Grant; F S Hagen; J L Kuijper; S L Matthewes; P J O'Hara; P O Sheppard; S D Stroop; D L Thompson
Journal:  Mol Pharmacol       Date:  1994-08       Impact factor: 4.436

10.  Osteoclasts express high levels of pp60c-src in association with intracellular membranes.

Authors:  W C Horne; L Neff; D Chatterjee; A Lomri; J B Levy; R Baron
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

View more
  21 in total

1.  Postmenopausal osteoporosis, T cells, and immune dysfunction.

Authors:  Steven L Teitelbaum
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-22       Impact factor: 11.205

Review 2.  Cytokines in the pathogenesis of osteoporosis.

Authors:  E Romas; T J Martin
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

3.  Lentivirus transduction of human osteoclast precursor cells and differentiation into functional osteoclasts.

Authors:  Margaret L Ramnaraine; Wendy E Mathews; Denis R Clohisy
Journal:  Bone       Date:  2011-10-01       Impact factor: 4.398

4.  Expression of typical osteoclast markers by PBMCs after PEG-induced fusion as a model for studying osteoclast differentiation.

Authors:  Luz M Castillo; Carlos A Guerrero; Orlando Acosta
Journal:  J Mol Histol       Date:  2017-03-25       Impact factor: 2.611

5.  Is GSN significant for hip BMD in female Caucasians?

Authors:  Fei-Yan Deng; Wei Zhu; Yong Zeng; Ji-Gang Zhang; Na Yu; Yao-Zhong Liu; Yong-Jun Liu; Qing Tian; Hong-Wen Deng
Journal:  Bone       Date:  2014-03-04       Impact factor: 4.398

Review 6.  Role of the immune system in postmenopausal bone loss.

Authors:  M Neale Weitzmann; Roberto Pacifici
Journal:  Curr Osteoporos Rep       Date:  2005-09       Impact factor: 5.096

7.  Alendronate reduces osteoclast precursors in osteoporosis.

Authors:  P D'Amelio; A Grimaldi; M A Cristofaro; M Ravazzoli; P A Molinatti; G P Pescarmona; G C Isaia
Journal:  Osteoporos Int       Date:  2009-12-01       Impact factor: 4.507

Review 8.  Osteoclasts-Key Players in Skeletal Health and Disease.

Authors:  Deborah Veis Novack; Gabriel Mbalaviele
Journal:  Microbiol Spectr       Date:  2016-06

9.  Proteomic analysis of circulating monocytes in Chinese premenopausal females with extremely discordant bone mineral density.

Authors:  Fei-Yan Deng; Yao-Zhong Liu; Li-Ming Li; Chen Jiang; Shan Wu; Yuan Chen; Hui Jiang; Fang Yang; Ji-Xian Xiong; Peng Xiao; Su-Mei Xiao; Li-Jun Tan; Xiao Sun; Xue-Zhen Zhu; Man-Yuan Liu; Shu-Feng Lei; Xiang-Ding Chen; Jing-Yun Xie; Gary G Xiao; Song-Ping Liang; Hong-Wen Deng
Journal:  Proteomics       Date:  2008-10       Impact factor: 3.984

10.  A novel approach for correction of crosstalk effects in pathway analysis and its application in osteoporosis research.

Authors:  Yu Zhou; Yunlong Gao; Chao Xu; Hui Shen; Qing Tian; Hong-Wen Deng
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.